NPPA and Parkinson disease: Numerous targets have been identified to facilitate PD treatment, such as chaperones, protein Abelson (c-Abl), glucocerebrosidase-1 (GBA-1), calcium, neuromelanin, ubiquitin-proteasome system (UPS), neuroinflammation, mitochondrial dysfunction, and KP.